Government planners have described a need for many thousands of additional ventilators in the event of a pandemic influenza or other large-scale medical emergency. Severe influenza often leads to respiratory distress which cannot be dealt with in the absence of mechanical ventilation. Since ventilators typically see less than 10% down-time in the US, there is little excess capacity to meet scaled up demand during an emergency. With a typical sales price greater than $15,000 for a new critical care ventilator, it is cost-prohibitive to stockpile a sufficient quantity of these devices. Furthermore, most ventilators in use today are ill-equipped for use in a mass casualty event or stockpiling, where electricity and oxygen may not be accessible, portability and durability are critical, and skilled users may be in short supply. OneBreath was founded by a group of physicians and engineers at Stanford University with the goal of developing a class-leading ventilator for rural critical care at an affordable price. The architecture of the OneBreath device is ideally suited to become the gold standard ventilator for emergency stockpiling. OneBreath is currently refining the design to ready it for Validation & Verification and FDA approval. Using the NASA Technology Readiness Level (TRL) system, OneBreath’s ventilator is currently at TRL 5.

Resilience - we're improving the broader infrastructure for responding to pandemic outbreaks.,Recovery - we're positioned to support in the recovery of those directly affected.

I have a prototype or a simple version I can show my customers

Matthew Callaghan MD – Founder, Chief Medical Officer. Dr. Callaghan is the Founder of OneBreath, an alumnus of Stanford’s Biodesign Program and a Consulting Associate Professor of Surgery at Stanford University. He has a background in product design and is the founder of two medical device companies including OneBreath. Matt is also a practicing physician at the San Francisco VA Medical Center, has published extensively, and served as principal investigator on multiple grants and trials.Douglas Vandine – Consulting Chief Technology Officer. Douglas is the former Director of Ventilator R&D at Covidien (Puritan-Bennett) where he was responsible for development and launch of the PB980 series ICU ventilator. Prior to working in the medical device R&D industry, Douglas was a certified Respiratory Therapist at Stanford Hospital for more than 15 years. He holds a bachelor’s degree in Physics and a graduate degree in Respiratory Therapy.Mohan Gurunathan – Project Manager and Engineering Lead. Mohan has a S.B. in Electrical Engineering and an M.Eng in Electrical Engineering & Computer Science, both from the Massachusetts Institute of Technology. He has 15 years of experience designing electronics, software, and FPGA code for a variety of industries and applications including medical devices, test equipment, data-acquisition systems, motor control, robotics, and aerospace products.

The United States, India, Singapore.

No